格隆汇2月25日｜有投资者在互动平台向中触媒提问：公司特种分子筛和催化剂营收占了主营绝大部 分，除此之外，近年公司在新材料研发和应用上有什么重大的、新的突破吗？ 中触媒回复称，近年公司持续加大研发投入强度，丰富产品矩阵，拓展产品应用与新材料领域，其中公 司已掌握人工合成高纯石英砂的全套生产工艺和合成核心技术，相关核心工艺已完成中试阶段的验证与 定型，纯度可达到5N以上；公司高纯氧化铝项目处于试生产阶段，纯度可达到5N。具体项目进展情况 请您关注公司后续披露的定期报告。 ...

Group 1 - The core viewpoint of the article highlights that Zhong Chumai has announced a delay in its "Environmental New Materials and Intermediates Project" to 2028, citing industry technology trends, market demand changes, and optimization of approval processes as reasons for the delay [1] - The company has confirmed that it has mastered the complete production process for artificial high-purity quartz sand and completed pilot testing, but there are still risks related to technological scaling and market competition in the industrialization process [1] - Zhong Chumai clarified that the construction of its iron-molybdenum catalyst production line is funded by its own capital, not through raised investment funds, to avoid overcapacity [1] Group 2 - In the recent stock performance, Zhong Chumai's share price experienced slight fluctuations, with a cumulative increase of 0.94% over the past week, closing at 29.00 yuan on February 9, 2026 [2] - The main capital flow showed a net outflow of funds over the past five days, with notable outflows on February 10 and February 11, while there was a net inflow on February 12 [2] - Institutional ratings indicate that in the past 90 days, three institutions have covered Zhong Chumai, with two giving a "Buy" rating and one an "Add" rating, reflecting market recognition of its business prospects [3]

证券代码：688267 证券简称：中触媒 中触媒新材料股份有限公司 2026 年第一次临时股东会会议资料 中触媒新材料股份有限公司 2026 年第一次临时股东会 会议资料 2026 年 2 月 中触媒新材料股份有限公司 2026 年第一次临时股东会会议资料 目录 | 2026 年第一次临时股东会会议须知 | 3 | | --- | --- | | 2026 年第一次临时股东会会议议程 | 6 | | 议案一：关于部分募投项目结项并将节余募集资金永久补充流动资金、 | | | 部分募投项目内部投资结构调整及延期的议案 7 | | 中触媒新材料股份有限公司 2026 年第一次临时股东会会议须知 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效 率，保证会议的顺利进行，根据《中华人民共和国公司法》、《中华人 民共和国证券法》、《上市公司股东会规则》以及《中触媒新材料股份 有限公司章程》、《中触媒新材料股份有限公司股东会议事规则》的相 关规定，特制定本会会议须知： 一、公司建议股东及股东代表采用网络投票方式参加本次股东会， 为确认出席会议的股东或其代理人或其他出席者的出席资格，会议工 作人员将对出席会议者的身 ...

Core Viewpoint - The company has completed the "Iron Molybdenum Catalyst Synthesis Technology Development" project and will focus on more urgent projects to avoid overcapacity [1] Group 1 - The company announced that the project related to iron molybdenum catalyst synthesis has been concluded and will be disclosed in the 2024 annual report [1] - The expansion of production lines is funded by the company's own resources and is being carried out on existing production lines [1] - The current production capacity is sufficient to meet market demand, leading the company to redirect funds to more pressing projects [1]

Investment Rating - The report assigns a rating of "Buy" for the company [5][12]. Core Insights - The company specializes in the research, production, and sales of specialty molecular sieves and catalytic new materials, with ongoing projects laying a foundation for future growth [2][20]. - The projected earnings per share (EPS) for 2025, 2026, and 2027 are estimated to be 1.16, 1.39, and 1.66 yuan respectively, with a target price set at 34.75 yuan based on a 25x PE valuation for 2026 [17][12]. - The company has established a comprehensive core process technology system covering the entire chemical industry chain, successfully developing multiple proprietary technology packages [12][20]. Financial Summary - Total revenue is projected to grow from 550 million yuan in 2023 to 1,528 million yuan in 2027, reflecting a compound annual growth rate (CAGR) of approximately 30.6% [4][13]. - Net profit attributable to shareholders is expected to increase from 77 million yuan in 2023 to 293 million yuan in 2027, with a significant rebound in 2024 showing an 89.2% increase [4][13]. - The company’s net asset return rate is projected to rise from 2.9% in 2023 to 8.9% in 2027, indicating improving profitability [4][13]. Production Capacity and Utilization - The company plans to increase its production capacity for specialty molecular sieves and catalysts by 3,000 tons in 2025 and an additional 3,300 tons by February 2026 [18][12]. - The utilization rates for the specialty molecular sieves and catalysts series are estimated to be 72%, 64%, and 77% for the years 2025 to 2027 respectively [18]. Market Position and Competitive Analysis - The company is positioned within the specialty molecular sieve industry, with comparable companies such as Jianlong Micro-Nano and Kaili New Materials showing an average PE of 23x for 2026 [19][17]. - The report emphasizes the strategic importance of the company's products in energy conservation and environmental protection, highlighting its role in the emerging materials sector [20].

Investment Rating - The report assigns a rating of "Buy" for the company [5][12]. Core Insights - The company specializes in the research, production, and sales of specialty molecular sieves and catalytic new materials, with ongoing projects laying a foundation for future growth [2][20]. - The projected earnings per share (EPS) for 2025, 2026, and 2027 are estimated to be 1.16, 1.39, and 1.66 yuan respectively, with a target price set at 34.75 yuan based on a 25x PE valuation for 2026 [12][17]. - The company has established a comprehensive core process technology system covering the entire chemical industry chain, successfully developing multiple proprietary technology packages [12][20]. Financial Summary - Total revenue is projected to grow from 550 million yuan in 2023 to 1,528 million yuan in 2027, reflecting a compound annual growth rate (CAGR) of approximately 30.6% [4][13]. - Net profit attributable to shareholders is expected to increase from 77 million yuan in 2023 to 293 million yuan in 2027, with a significant rebound in 2024 showing an 89.2% increase [4][13]. - The company’s net asset return rate is projected to rise from 2.9% in 2023 to 8.9% in 2027, indicating improving profitability [4][13]. Production Capacity and Utilization - The company plans to increase its production capacity for specialty molecular sieves and catalysts by 3,000 tons in 2025 and an additional 3,300 tons for environmental catalysts by February 2026 [18][20]. - The expected capacity utilization rates for specialty molecular sieves and catalysts are projected to be 72%, 64%, and 77% for 2025, 2026, and 2027 respectively [18]. Comparable Company Valuation - The report compares the company with peers in the molecular sieve industry, with an average PE of 23x for 2026 among comparable companies [17][19].

证券代码：688267 证券简称：中触媒 公告编号：2026-001 中触媒新材料股份有限公司 关于部分募投项目结项并将节余募集资金永久补充流动 资金、部分募投项目内部投资结构调整及延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意中触媒新材料股份有限公司首 次公开发行股票注册的批复》（证监许可[2022]10号），公司发行人民币普通股（A 1 中触媒新材料股份有限公司（以下简称"公司"）于2026年2月4日召开第四届董事 会审计委员会第五次会议，于2026年2月5日召开第四届董事会第七次会议，审议通 过了《关于部分募投项目结项并将节余募集资金永久补充流动资金、部分募投 项目内部投资结构调整及延期的议案》。同意募投项目"特种分子筛、环保催 化剂、汽车尾气净化催化剂产业化项目"结项，该项目结项后节余募集资金 1,446.25万元,其中59.48万元优先用于补充"环保新材料及中间体项目"投资 增加部分，1,386.77万元节余募集资金用于 ...

证券代码：688267 证券简称：中触媒 公告编号：2026-003 中触媒新材料股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 2026年第一次临时股东会 召开日期时间：2026 年 2 月 26 日 14 点 30 分 召开地点：辽宁省大连普湾新区松木岛化工园区中触媒新材料股份有限公司 学术报告厅 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2026 年 2 月 26 日 至2026 年 2 月 26 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 股东会召开日期：2026年2月26日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 （二） 股东会召集人：董事会 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 （四） 现场会议召开的日期、时间和地点 东会召开当 ...

证券代码：688267 证券简称：中触媒 公告编号：2026-002 本议案尚需提交股东会审议。 具体内容详见公司披露于上海证券交易所网站（www.sse.com.cn）的相关公 告及文件。 (二)审议通过《关于召开 2026 年第一次临时股东会的议案》 中触媒新材料股份有限公司 第四届董事会第七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 中触媒新材料股份有限公司（以下简称"公司"）第四届董事会第七次会议 于 2026 年 2 月 5 日在公司会议室通过现场和通讯相结合的形式召开。本次会议 的通知于 2026 年 1 月 27 日通过电话及邮件方式通知全体董事。会议应到董事 9 名，实到董事 9 名，会议由董事长李进主持。会议的召集和召开程序符合有关法 律、行政法规、部门规章、规范性文件和公司章程的规定。会议决议合法、有效。 二、董事会会议审议情况 会议经全体参会董事表决，形成决议如下： (一)审议通过《关于部分募投项目结项并将节余募集资金永久补充流动资金、 部分募投项目内部投资 ...

申万宏源证券承销保荐有限责任公司 关于中触媒新材料股份有限公司 部分募投项目结项并将节余募集资金永久补充流动资金、部分募投项目 内部投资结构调整及延期的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或"保 荐机构"）作为中触媒新材料股份有限公司（以下简称"中触媒"、"上市公司" 或"公司"）首次公开发行股票并在科创板上市的保荐机构，根据《证券发行上市 保荐业务管理办法》《上海证券交易所科创板股票上市规则》《上市公司募集资金 监管规则》等有关法律、法规的规定，对中触媒部分募投项目结项并将节余募集资 金永久补充流动资金、部分募投项目内部投资结构调整及延期的事项进行了审慎核 查，并出具核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意中触媒新材料股份有限公司首 次公开发行股票注册的批复》（证监许可[2022]10号），公司发行人民币普通股（A 股）4,405万股，发行价格为人民币41.90元/股，募集资金总额为人民币184,569.50 万元，扣除与发行有关的费用人民币15,454.86万元（不含增值税），实际募集资金 净额为人民币169,114.64万元。上 ...